|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | GlaxoSmithKline |
|---|---|
| Information provided by: | GlaxoSmithKline |
| ClinicalTrials.gov Identifier: | NCT00708305 |
Purpose
This study is to evaluate the amount of fluoride in plaque fluid after brushing iwth fluoride dentifrices
| Condition | Intervention | Phase |
|---|---|---|
|
Healthy Volunteers |
Drug: fluoride |
Phase III |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Bio-availability Study Intervention Model: Crossover Assignment Masking: Double-Blind Primary Purpose: Treatment |
| Official Title: | Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes |
| Estimated Enrollment: | 53 |
| Study Start Date: | June 2008 |
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Oral
Exclusion Criteria:
Medication
Dental
Contacts and Locations| United States, Indiana | |
| GSK Clinical Trials Call Centre | Recruiting |
| Indianapolis, Indiana, United States, 46202 | |
| Contact: GSK Clinical Trials Call center 877-379-3718 | |
| Study Director: | GSK Clinical Trials, DDS | GlaxoSmithKline |
More Information
| ClinicalTrials.gov Identifier: | NCT00708305 History of Changes |
| Other Study ID Numbers: | T3508570 |
| Study First Received: | July 1, 2008 |
| Last Updated: | July 1, 2008 |
| Health Authority: | United States: Food and Drug Administration |
|
fluoride plaque fluid toothpaste |
|
Fluorides Cariostatic Agents Protective Agents Physiological Effects of Drugs Pharmacologic Actions |